Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine Effects on Platelet Calcium in Hypertensive and Depressed Patients
NCT00018759Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Paroxetine with Placebo (2 arms). Primary endpoint: Platelet cytosolic calcium response to serotonin. Started Mar 2001; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00018759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018759.